A Brief Review of Anal Cancer Screening Methods for Prevention and Earlier Diagnosis
- PMID: 40242694
- PMCID: PMC11999906
- DOI: 10.7759/cureus.80686
A Brief Review of Anal Cancer Screening Methods for Prevention and Earlier Diagnosis
Abstract
Anal cancer has shown increasing incidence and death rates in recent years despite their lower incidence rate in the general population. Various risk factors contribute to this upward trend, with sexual risk factors playing a notable role. Additionally, there is a strong correlation between patients' survival rates and clinical outcomes with tumor stages, underscoring the importance of developing effective screening methods for anal cancer, particularly in high-risk groups. The well-established link between human papillomavirus (HPV) infection and anal tumors, combined with the success of cervical cancer screening programs, has led to some similarities in anal cancer screening strategies. However, the absence of established guidelines for anal cancer screening indicates a need for further research to assess the efficacy of these methods across different populations. Such research would enhance knowledge, awareness, and motivation for participation in screening programs. In this review, we will discuss various anal screening approaches, including their characteristics, novel biomarkers, and molecular methods, as well as prevention strategies and existing limitations in anal screening.
Keywords: anal cytology; anoscopy; anus neoplasms; human papillomavirus; sexual behavior.
Copyright © 2025, Parhizkar Roudsari et al.
Conflict of interest statement
Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.
Figures

Similar articles
-
Anal dysplasia screening: an evidence-based analysis.Ont Health Technol Assess Ser. 2007;7(4):1-43. Epub 2007 Jun 1. Ont Health Technol Assess Ser. 2007. PMID: 23074504 Free PMC article.
-
Comprehensive Review of Anal Cytology.Acta Cytol. 2023;67(2):185-194. doi: 10.1159/000528532. Epub 2023 Jan 10. Acta Cytol. 2023. PMID: 36626881 Review.
-
A comprehensive review of anal cancer-with a special focus on anal cytology.J Am Soc Cytopathol. 2024 Mar-Apr;13(2):122-140. doi: 10.1016/j.jasc.2023.11.002. Epub 2023 Nov 10. J Am Soc Cytopathol. 2024. PMID: 38097479 Review.
-
Prevalence of high-risk human papillomavirus DNA and mRNA and its association with abnormal anal cytology in the Czech male anal cancer screening cohort.Diagn Cytopathol. 2021 Nov;49(11):1188-1195. doi: 10.1002/dc.24873. Epub 2021 Sep 16. Diagn Cytopathol. 2021. PMID: 34529895
-
The Study of the Prevention of Anal Cancer (SPANC): design and methods of a three-year prospective cohort study.BMC Public Health. 2013 Oct 9;13:946. doi: 10.1186/1471-2458-13-946. BMC Public Health. 2013. PMID: 24107134 Free PMC article.
References
-
- Cancer statistics, 2022. Siegel RL, Miller KD, Fuchs HE, Jemal A. CA Cancer J Clin. 2022;72:7–33. - PubMed
-
- Malignant tumors of the anal canal: the spectrum of disease, treatment, and outcomes. Klas JV, Rothenberger DA, Wong WD, Madoff RD. Cancer. 1999;85:1686–1693. - PubMed
-
- Cytology in anal cancer screening: practical review for clinicians. Albuquerque A. Acta Cytol. 2020;64:281–287. - PubMed
Publication types
LinkOut - more resources
Full Text Sources